A detailed history of Verition Fund Management LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 9,227 shares of TMDX stock, worth $803,763. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,227
Previous 14,085 34.49%
Holding current value
$803,763
Previous $2.12 Million 31.73%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$135.68 - $176.11 $659,133 - $855,542
-4,858 Reduced 34.49%
9,227 $1.45 Million
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $527,874 - $1.09 Million
7,269 Added 106.65%
14,085 $2.12 Million
Q1 2024

May 14, 2024

BUY
$70.86 - $89.93 $482,981 - $612,962
6,816 New
6,816 $503,000
Q3 2023

Nov 14, 2023

BUY
$53.47 - $96.07 $369,049 - $663,075
6,902 New
6,902 $377,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.77B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.